ARID1A loss activates MAPK signaling via DUSP4 downregulation.
Jayaprakash MandalZheng-Cheng YuIe-Ming ShihTian-Li WangPublished in: Journal of biomedical science (2023)
Our findings suggest that ARID1A protein transcriptionally modulates DUSP4 expression by remodeling chromatin, subsequently inactivating the MAPK pathway, leading to tumor suppression. The ARID1A-DUSP4-MAPK axis may be further considered for developing targeted therapies against ARID1A-mutated cancers.